Allogene Overland Biopharm Appoints Shuyuan Yao as Chief Executive Officer

Veteran pharmaceutical executive with proven cell and gene therapy development experience in Asia, formerly of WuXi AppTec Shanghai and the joint venture JW Therapeutics SOUTH SAN FRANCISCO, Calif. & BOSTON & SHANGHAI--(BUSINESS WIRE)--Allogene Over...

Full "IntellAsia: Resources" article